Cargando…
Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients
PURPOSE: This study aimed to investigate the correlation between mSEPT9 and tumor burden as well as the role of mSEPT9 in monitoring colorectal cancer (CRC) patients. METHODS: A total of 309 patients were recruited and received mSEPT9 detection in this retrospective study. Clinicopathologic characte...
Autores principales: | Jiang, Huiqin, Yu, Qian, Chen, Xinning, Zhang, Chunyan, Shen, Junfei, Shen, Minna, Yang, Yihui, Wang, Beili, Pan, Baishen, Guo, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605145/ https://www.ncbi.nlm.nih.gov/pubmed/34591323 http://dx.doi.org/10.1002/jcla.24030 |
Ejemplares similares
-
Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma
por: Huang, Fei, et al.
Publicado: (2022) -
Opportunistic screening and survival prediction of digestive cancers by the combination of blood mSEPT9 with protein markers
por: Song, Lele, et al.
Publicado: (2020) -
Methylated Septin9 (mSEPT9): A Promising Blood-Based Biomarker for the Detection and Screening of Early-Onset Colorectal Cancer
por: Loomans-Kropp, Holli A., et al.
Publicado: (2022) -
Postoperative circulating tumor DNA testing based on tumor naïve strategy after liver metastasis surgery in colorectal cancer patients
por: Jiang, Huiqin, et al.
Publicado: (2023) -
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma
por: Oussalah, Abderrahim, et al.
Publicado: (2018)